Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

NATerminatedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

July 20, 2009

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Short Children Born Small for Gestational Age (SGA)
Interventions
OTHER

Bloodsampling

Bloodsampling

Trial Locations (23)

144

Novartis Investigative Site, Tbilisi

3526

Novartis Investigative Site, Miskolc

20395

Novartis Investigative Site, Bucharest

25734

Novartis Investigative Site, Kielce

53757

Novartis Investigative Site, Nordrhein Westfalen

80337

Novartis Investigative Site, München

85667

Novartis Investigative Site, Bydgoszcz

700111

Novartis Investigative Site, Lasi

400 11

Novartis Investigative Site, Ústí nad Labem

500 05

Novartis Investigative Site, Hradec Králové

150 06

Novartis Investigative Site, Prague

60-572

Novartis Investigative Site, Poznai

50-311

Novartis Investigative Site, Wroclaw

50-368

Novartis Investigative Site, Wroclaw

35-301

Novartis Investigative Site, Rzeszów

40-752

Novartis Investigative Site, Katowice

41-800

Novartis Investigative Site, Zabrze

80 952

Novartis Investigative Site, Gdansk

30-663

Novartis Investigative Site, Krakow

93-338

Novartis Investigative Site, Lodz

71-252

Novartis Investigative Site, Szczecin

04 730

Novartis Investigative Site, Warsaw

CLUJ

Novartis Investigative Site, Cluj-Napoca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sandoz

INDUSTRY